UCI study also shows novel analgesic to be nonaddictive
A compound derived from a traditional Chinese herbal medicine has been found effective at alleviating pain, pointing the way to a new nonaddictive analgesic for acute inflammatory and nerve pain, according to UC Irvine pharmacology researchers.
Working with Chinese scientists, Olivier Civelli and his UC Irvine colleagues isolated a compound called dehydrocorybulbine (DHCB) from the roots of the Corydalis yanhusuo plant. In tests on rodents, DHCB proved to diminish both inflammatory pain, which is associated with tissue damage and the infiltration of immune cells, and injury-induced neuropathic pain, which is caused by damage to the nervous system. This is important because there are no current adequate treatments for neuropathic pain.
Moreover, the researchers found that DHCB did not generate the tolerance seen with continued use of most conventional pain relievers, such as morphine.
“Today the pharmaceutical industry struggles to find new drugs. Yet for centuries people have used herbal remedies to address myriad health conditions, including pain. Our objective was to identify compounds in these herbal remedies that may help us discover new ways to treat health problems,” said Civelli, the Eric L. & Lila D. Nelson Chair in Neuropharmacology. “We’re excited that this one shows promise as an effective pharmaceutical. It also shows a different way to understand the pain mechanism.”
Study results appear in the Jan. 20 issue of Current Biology.
They are the product of a collaboration between two teams separated by the Pacific Ocean. As traditional Chinese medicine gains greater acceptance in Western medical practice, Xinmiao Liang at the Dalian Institute of Chemical Physics in China and his group have been working to create an “herbalome” of all the compounds in plant extracts that display pharmacological properties. The UC Irvine team suggested applying “reverse pharmacology” – a novel drug discovery approach that Civelli devised about 25 years ago – to the herbalome project.
Together they screened 10 traditional Chinese medicines known as analgesics, testing nearly 500 compounds for their pain-relief abilities. Only DHCB in corydalis induced a reproducible effect.
Corydalis is a flowering herbal plant that grows in Siberia, Northern China and Japan. People utilize its root extract to alleviate menstrual cramps, chest pain and abdominal pain. It’s been previously studied for its analgesic properties, but this is the first time DHCB has been identified, extracted and tested.
Chronic neuropathic pain affects more than 50 million Americans, yet management of this pain remains a major clinical challenge due to the poor results and severe side effects of conventional analgesics. Civelli said that drawing upon traditional Chinese medical-herbal products could lead to a breakthrough treatment for these patients.
DHCB needs to be evaluated for any toxicity before it can be developed as a drug. It’s also possible that if the compound is chemically modified, a more potent pharmaceutical may be found. While DHCB is not currently available, it is part of the Corydalis yanhusuo root or extracts that can be purchased in health stores or online.
The Latest on: Alleviating pain
via Google News
The Latest on: Alleviating pain
- Suffer from low-back pain? This stretch can helpon August 26, 2021 at 2:53 pm
But if improper form during exercise or the strain of daily movements is causing you discomfort, the right stretches can help release tension and aid in recovery. Child's pose is one of my favorite ...
- Study: Chronic Pain Patients Report Improved Quality of Life Following Medical Cannabis Useon August 26, 2021 at 1:36 pm
Patients with chronic pain conditions report improvements in their health-related quality of life following the use of cannabis, according to data published in the journal Medical Cannabis and ...
- Harvard MedTech Announces Breakthrough in Treatment of Trauma and Pain: Virtual Reality Technology, Behavioral Intervention, and AIon August 26, 2021 at 4:45 am
Harvard MedTech, a breakthrough digital health company, is tapping the new science of how the brain works by using virtual reality experiences, psychosocial support, digital engagement and proprietary ...
- Strong week for Compañía de Minas BuenaventuraA (NYSE:BVN) shareholders doesn't alleviate pain of one-year losson August 26, 2021 at 3:36 am
Investors in Compañía de Minas Buenaventura S.A.A. ( NYSE:BVN) have tasted that bitter downside in the last year, as the share price dropped 48%. That contrasts poorly with the market return of 32%.
- You Might Want to Consider a Knee Brace If You’re Experiencing Some Pain While Runningon August 25, 2021 at 6:40 am
Here’s what two experts have to say about when it’s beneficial and when knee pain signals that you need a break.
- Keep back pain at bay with these basic approacheson August 25, 2021 at 2:00 am
Back pain is a part of life for many people. The American Chiropractic Association says 31 million Americans experience low back pain at any given time, and experts estimate that ...
- The pain switchon August 24, 2021 at 2:00 pm
Professor Fan Wang’s research is zeroing in on brain circuits that control the perception of pain. Her work could one day make it possible to manage pain without opioids.
- This memory foam pillow can help alleviate back and neck pain — and it's on sale for $70on August 24, 2021 at 8:33 am
Damaged cervical curve can cause a handful of painful problems that can make our day-to-lives uncomfortable and prevent us from doing the things we love — including sleeping! The Mkicesky Side Sleeper ...
- ‘The Way Out’ Offers a Thoughtful New Approach to Treat Chronic Painon August 24, 2021 at 5:00 am
In 'The Way Out,' author Alan Gordon dives into the mechanisms of chronic pain and explores a powerful, proven method to relieve it.
- Strong week for Viridian Therapeutics (NASDAQ:VRDN) shareholders doesn't alleviate pain of three-year losson August 23, 2021 at 11:43 am
Viridian Therapeutics, Inc. (NASDAQ:VRDN) shareholders should be happy to see the share price up 15% in the last week. But only the myopic could ignore the astounding decline over three years. In that ...
via Bing News